Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2013


European Pre-Filled Syringes

28 Jan 2013 - 29 Jan 2013 - London, UK



Bookmark and Share


SMi are proud to present the return of their flagship Pre-Filled Syringes Conference. Now in its 5th year, the 2013 conference will bring together experts from a range of industry perspectives to discuss solutions and strategies within key issues such as syringe formulations for biosimilars and other biologics, extractable and leachables, primary packaging developments and filling and finishing. As well as exclusive presentations on the latest commercial and regulatory developments across Europe and further afield, the event will act as a unique forum for attendees to learn, make connections and explore new ideas.

**New for 2013: First 25 Pharmaceutical Companies register for £899 including Networking Dinner at the Gilgamesh**

KEY BENEFITS OF ATTENDING:

Explore the challenges for the development of HCLF biologics with key industry professionals

Consider the effects of leachables and extractables and evaluating interactions between formulation and containers

Develop your understanding of regulatory compliance from pharmaceutical companies and the MHRA

Hear from leading healthcare professionals on the growing use of pre-filled syringes at the patient ‘front line’

Streamline the filling and closing process by exploring facility design strategies and syringe development line techniques

Discuss the latest in vendor procurement and outsourcing strategies

Network with and learn from key industry professionals, leading academics and healthcare representatives

Visit our website here: www.smi-online.co.uk/2013prefilledsyringes19.asp

Alternatively Contact Fateja Begum on telephone +44 (0) 20 7827 6184 or email on fbegum@smi-online.co.uk



Further information
Scientific News
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Computerized Flexible Needles Prove Themselves in Biological Tissue
The advantage of the system is that you can avoid obstacles with the needles or critical tissues and that the system during the insertion of the needle in real time can adjust the path if, for example, the tissue deforms.
DARWIN 2 24-week Monotherapy Data in RA Confirm Previous Results
Safety profile in DARWIN 2 consistent with previous filgotinib RA studies.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
Agricultural Intervention Improves HIV Outcomes
A multifaceted farming intervention can reduce food insecurity while improving HIV outcomes in patients in Kenya, according to a randomized, controlled trial led by researchers at UC San Francisco.
Overdose of Vitamin D in Teenagers May Lead to Increased Cholesterol Levels
Dosing obese teens with vitamin D shows no benefits for their heart health or diabetes risk, and could have the unintended consequences of increasing cholesterol and fat-storing triglycerides. These are the latest findings in a series of Mayo Clinic studies in childhood obesity.
Phase 2 Trials Underway for New Single Dose Malaria Treatment
The new drug, which prevents the malaria parasite from reproducing and spreading, is now undergoing Phase II clinical trials in humans.
Promising Drug for Parkinson's Disease
A drug which has already been in use for decades to treat liver disease could be an effective treatment to slow down progression of Parkinson’s disease, scientists from the University of Sheffield have discovered.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!